GILD's Remdesivir and Capricor's experimental drug
Post# of 714
Remdesivir seems to help people who are moderately ill avoid getting sicker, so they stay out of the ICU.
CAPR's therapy addresses cytokine storm. They let 6 critically ill (terminal) patients on ventilators try it as a last resort, under Compassionate Use program. All 6 are still alive, 4 are off ventilator and out of ICU, 2 still on ventilator but improving.